Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $806M. The Maz Rating grades it against the other companies in its sector.
Ironwood Pharmaceuticals, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $4.87, Ironwood Pharmaceuticals, Inc. trades at 5.3x trailing earnings and 2.0x sales, with an EV/EBITDA of 2.8. Over the last twelve months it generated about $404M of revenue and $151M of net income. It runs a gross margin of 99.9%, an operating margin of 62.8% and a net margin of 37.4%. It shows return on equity of -93.4%, return on invested capital of 64.0% and a free cash flow yield of 25.6%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 6.51. Over the past 52 weeks the share price ranged from $2.95 to $5.78, with a beta of 0.24.
Ironwood Pharmaceuticals, Inc. does not currently pay a dividend.
30 Wall Street analyst ratings cover the stock: 11 Buy, 16 Hold and 3 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.